Home > Products > Featured products
Cat. No. Product name CAS No.
DC21101 BDCRB Featured

BDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA..

142356-43-2
DC10860 BDP5290 Featured

BDP5290 is a potent inhibitor of both ROCK and MRCK with IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.

1817698-21-7
DC20765 BDT001 Featured

BDT001 is a first-in-class, non-competitive FLT3 negative allosteric modulator, effectively prevents extracellular cytokine FL binding to FLT3 with IC50 of 11 uM.

823837-22-5
DC9718 BEBT-908(CUDC-908) Featured

BEBT-908(CUDC-908)is a novel PI3K/HDAC inhibitor.

1235449-52-1
DC9964 BEC hydrochloride Featured

BEC is a boronic acid-based arginine analog that acts as a slow-binding, competitive transition state inhibitor of arginase I and II (Ki = 310 nM for human recombinant type II arginase, pH 7.5).

222638-67-7
DC8809 Bedaquiline fumarate Featured

Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis.

845533-86-0
DC21007 Befiradol Featured

Befiradol (F13640, NLX 112) is a highly potent, selective 5-HT1A receptor agonist with Ki of 2.7 nM.

208110-64-9
DC7082 Belinostat (PXD101) Featured

Belinostat (PXD101) is a novel pan-HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors.

414864-00-9
DC10448 Belizatinib(TSR-011) Featured

Belizatinib(TSR-011) is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity.

1357920-84-3
DC11470 Belotecan hydrochloride(CKD-602) Featured

Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic and water-soluble camptothecin derivative.

213819-48-8
DC12278 Belvarafenib Featured

Belvarafenib is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively.

1446113-23-0
DC6908 Bendamustine HCL (SDX-105, Cytostasane) Featured

Bendamustine HCL (Ribomustin, Treanda, SDX-105) is a DNA-damaging agent with IC50 of 50 μM.

3543-75-7
DC10701 Benzamide (NSC 404988) Featured

Benzamide (NSC 404988) is a bioactive compound.

7461-38-3
DC26053 Benzamil (hydrochloride) Featured

Benzamil hydrochloride is a specific and potent sodium channel (ENaC) blocker.

161804-20-2
DC8895 benzbromaron Featured

Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.

3562-84-3
DC20028 Benznidazol (Ro 07-1051; Ro 71051) Featured

Benznidazol (Ro 07-1051) is an antiparasitic medication, with an IC50 of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease.

22994-85-0
DCAPI1500 Bepotastine Besilate Featured

Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist.

190786-44-8
DC8898 Bepotastine Featured

Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor.

125602-71-3
DC11403 Bepridil hydrochloride Featured

Bepridil hydrochloride is a calcium channel blocker, with antianginal activity.

68099-86-5
DC4143 Besifloxacin HCl Featured

Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic.

405165-61-9
DC21382 EIDD-1931(NHC) Featured

EIDD-1931 (β-d-N4-Hydroxycytidine, NHC) inhibits both murine hepatitis virus (MHV) (EC50 of 0.17 μM) and Middle East respiratory syndrome CoV (MERS-CoV) (EC50 of 0.56 μM) with minimal cytotoxicity. It also inhibits SARS-CoV-2 and multiple 2 endemic, epide

3258-02-4
DC10655 3-Guanidinopropionic acid Featured

Beta-guanidinopropionic acid is a novel creatine kinase inhibitor.

353-09-3
Page 46 / Total 440 FirstPrevNextLastGoto